• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝脏导向治疗肝结直肠转移的演变。

The evolution of liver-directed treatments for hepatic colorectal metastases.

出版信息

Oncology (Williston Park). 2014 Nov;28(11):991-1003.

PMID:25403632
Abstract

The liver is the most common site of metastases from colorectal cancer. Over the past 3 decades, surgical resection has proved to be the most effective and potentially curative therapy for such metastases. This article will review the current practice of hepatic resection for colorectal liver metastases, including the possibility of combined resection of hepatic metastases at the time of resection of the primary cancer. Effective use of neoadjuvant and adjuvant chemotherapy has further expanded the pool of treatable patients. Most recently, ablative therapies based on needle-delivered thermoablation or radiation therapy have become additional weapons for effective treatment. The relative roles and combined use of these local therapies will be highlighted in this article. Overall, the recent combined advances in surgery, radiation therapy, ablative therapy, and chemotherapy have provided more patients with a chance for long-term survival.

摘要

肝脏是结直肠癌转移的最常见部位。在过去的 30 年中,手术切除已被证明是治疗此类转移的最有效和潜在的治愈方法。本文将回顾目前用于结直肠癌肝转移的肝切除术,包括在切除原发性癌症时联合切除肝转移的可能性。新辅助和辅助化疗的有效应用进一步扩大了可治疗患者的范围。最近,基于针输送的热消融或放射治疗的消融疗法已成为有效治疗的附加手段。本文将重点介绍这些局部治疗方法的相对作用和联合应用。总的来说,最近在手术、放射治疗、消融治疗和化疗方面的综合进展为更多患者提供了长期生存的机会。

相似文献

1
The evolution of liver-directed treatments for hepatic colorectal metastases.肝脏导向治疗肝结直肠转移的演变。
Oncology (Williston Park). 2014 Nov;28(11):991-1003.
2
[Diagnosis and treatment of liver metastases].[肝转移瘤的诊断与治疗]
Gan To Kagaku Ryoho. 2010 Feb;37(2):194-9.
3
[Liver resection after downstaging with neoadjuvant chemotherapy for "unresectable" colorectal metastases].新辅助化疗降期后对“不可切除”的结直肠癌肝转移灶进行肝切除术
Chir Ital. 2004 May-Jun;56(3):351-7.
4
Neoadjuvant and adjuvant therapy in relation to surgery for colorectal liver metastases.结直肠癌肝转移手术相关的新辅助治疗和辅助治疗
Scand J Gastroenterol. 2012 Mar;47(3):286-95. doi: 10.3109/00365521.2012.640826. Epub 2011 Dec 19.
5
[Prediction of treatment outcome after adjuvant loco-regional chemotherapy following liver resection for colorectal metastases--preliminary results].[结直肠癌肝转移灶切除术后辅助局部区域化疗治疗结果的预测——初步结果]
Rozhl Chir. 2006 Mar;85(3):124-8.
6
Safety, tolerability, and efficacy of oxaliplatin-based adjuvant chemotherapy after curative resection of hepatic or extrahepatic metastases of Stage IV colorectal cancer.基于奥沙利铂的辅助化疗在IV期结直肠癌肝转移或肝外转移根治性切除术后的安全性、耐受性和疗效。
Cancer Chemother Pharmacol. 2015 Jul;76(1):133-9. doi: 10.1007/s00280-015-2780-1. Epub 2015 May 21.
7
Chemotherapy and molecular-targeted treatment for unresectable hepatic metastases: a Japanese perspective.不可切除的肝转移瘤的化疗和分子靶向治疗:日本视角。
J Hepatobiliary Pancreat Sci. 2012 Sep;19(5):515-22. doi: 10.1007/s00534-012-0517-7.
8
Liver Metastases in Colorectal Cancer.
Am Soc Clin Oncol Educ Book. 2016;35:e186-92. doi: 10.1200/EDBK_159185.
9
[Choice of surgical strategy for colorectal liver metastases depending on clinical and pathological response to neoadjuvant chemo- and targeted therapy].[根据新辅助化疗和靶向治疗的临床及病理反应选择结直肠癌肝转移的手术策略]
Orv Hetil. 2010 Nov 21;151(47):1956-60. doi: 10.1556/OH.2010.28988.
10
Management of liver metastases from colorectal cancer.结直肠癌肝转移的管理
Oncology (Williston Park). 2006 Sep;20(10):1161-76, 1179; discussion 1179-80, 1185-6.

引用本文的文献

1
A novel irinotecan-lipiodol nanoemulsion for intravascular administration: pharmacokinetics and biodistribution in the normal and tumor bearing rat liver.一种新型伊立替康-碘油纳米乳剂经血管内给药:在正常和荷瘤大鼠肝脏中的药代动力学和生物分布。
Drug Deliv. 2021 Dec;28(1):240-251. doi: 10.1080/10717544.2020.1869863.
2
Embolotherapy for Hepatic Oncology: Current Perspectives and Future Directions.肝脏肿瘤的栓塞治疗:当前观点与未来方向
Dig Dis Interv. 2020 Jun;4(2):134-147. doi: 10.1055/s-0040-1712146. Epub 2020 May 25.
3
Local immunomodulation combined to radiofrequency ablation results in a complete cure of local and distant colorectal carcinoma.
局部免疫调节联合射频消融可实现局部和远处结直肠癌的完全治愈。
Oncoimmunology. 2019 Jan 10;8(3):1550342. doi: 10.1080/2162402X.2018.1550342. eCollection 2019.
4
Selecting incision-dominant cases for robotic liver resection: towards outpatient hepatectomy with rapid recovery.选择以切口为主导的病例进行机器人肝脏切除术:迈向快速康复的门诊肝切除术。
Hepatobiliary Surg Nutr. 2018 Apr;7(2):77-84. doi: 10.21037/hbsn.2017.05.05.
5
Clinical outcomes of Y90 radioembolization for recurrent hepatocellular carcinoma following curative resection.Y90 放射性栓塞治疗根治性切除术后复发性肝细胞癌的临床结果。
Eur J Nucl Med Mol Imaging. 2017 Dec;44(13):2195-2202. doi: 10.1007/s00259-017-3792-3. Epub 2017 Aug 15.
6
Predictors of recurrence after a first hepatectomy for colorectal cancer liver metastases: a retrospective analysis.结直肠癌肝转移首次肝切除术后复发的预测因素:一项回顾性分析。
World J Surg Oncol. 2014 Dec 20;12:391. doi: 10.1186/1477-7819-12-391.